CPT® Code 0610T

Magnetic resonance spectroscopy, determination and localization of discogenic pain (cervical, thoracic, or lumbar); transmission of biomarker data for software analysis

Magnetic resonance spectroscopy (MRS) is a sophisticated imaging technique that allows for the assessment of biochemical processes within the body, particularly in relation to discogenic pain. This procedure is specifically designed to identify the presence of certain biomarkers that are indicative of painful intervertebral discs in the cervical, thoracic, or lumbar regions of the spine. By utilizing a strong magnetic field, MRS enables the differentiation of various molecules based on their unique chemical structures, which resonate at distinct frequencies. This property is crucial for diagnosing conditions related to disc degeneration, as it provides insights into the structural integrity of the discs. Key biomarkers such as proteoglycan and collagen are measured to evaluate the health of the disc, while lactic acid, alanine, and propionate levels are analyzed to assess acidity and metabolic activity within the disc. The ratios of these biomarkers are instrumental in calculating the potential for pain, as they reflect the biochemical environment of the disc. For instance, the accumulation of lactic acid can lead to a decrease in disc pH, which is associated with accelerated degeneration. The MRS procedure involves the careful selection of a single voxel geometry that targets the disc nucleus while avoiding the vertebral body, ensuring accurate data collection. Once the imaging is completed, the acquired data is transmitted for further analysis using specialized software, facilitating a comprehensive evaluation of the disc's condition and aiding in the determination of appropriate surgical outcomes.